Oaktree Acquisition Corp. II (OACB) to Combine with Alvotech in $2.25Bn Deal
Warning: DOMDocument::loadHTML(): Unexpected end tag : p in Entity, line: 5 in /var/convesio/wordpress/wp-content/plugins/spacinsider-upqode/src/Start.php on line 90
Oaktree II (NYSE:OACB) has entered into a definitive agreement to combine with biopharma company Alvotech at an enterprise value of $2.25 billion, or 4.6x its 2025E EBITDA. Reykjavik, Iceland-based Alvotech is developing medicines that are biosimilar to branded pharmaceuticals on the market, potentially providing them to the market at lower prices. The combined company is
Read More